Head-to-Head

Aclaris Therapeutics, Inc. vs. Eli Lilly & Co.

ACRS

Aclaris Therapeutics, Inc.

$3.70 -13.35%

VS LLY

Eli Lilly & Co.

$1157.49 +1.26%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ACRSLLY
Market Cap $628.54 million $1.02 trillion

LLY leads on 1 of 1 size & scale factors.

Dividend

ACRSLLY
Dividend Yield — 0.60%

ACRS and LLY split the dividend factors evenly.

Risk & Sentiment

ACRSLLY
Short Interest 2.38% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: ACRS overview, ACRS financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.